* Minerva Neurosciences Inc NERV.OQ NERV.O is expected
to show
no change in quarterly revenue when it reports results on
November 5 (estimated) for the period ending September 30 2024
*
* LSEG's mean analyst estimate for Minerva Neurosciences
Inc is
for a loss of $1.01 per share.
* The one available analyst rating on the shares is
"hold".
* The mean earnings estimate of analysts was unchanged in
the last
three months.
* Wall Street's median 12-month price target for Minerva
Neurosciences Inc is 5.00, above its last closing price
of $2.40.
This summary was machine generated November 1 at 14:04 GMT. All
figures in US dollars unless otherwise stated. (For questions
concerning the data in this report, contact
Estimates.Support@lseg.com. For any other questions or feedback,
contact RefinitivNewsSupport@thomsonreuters.com)